We have located links that may give you full text access.
Secondary Aneurysmal Bone Cyst of the Scapula Treated by CT Guided Percutaneous Polidocanol Injection - A Case Report.
Journal of Clinical and Diagnostic Research : JCDR 2016 December
Aneurysmal Bone Cyst (ABC) is a rare benign tumour, usually affecting early age group and at the metaphysis of long bones. Scapular ABC's are even more rare, especially successfully treated cases. Standard treatment methods like curettage have high recurrence rates hence, adjuvant therapy may be required to avoid recurrence. Polidocanol sclerotherapy is becoming popular because of its safety and efficacy and is being tried successfully for both active as well as aggressive primary ABC of size 3-5cm. We used the same principle in a large secondary ABC of the scapula, which to the best of our knowledge has not been yet reported. The index case is that of a 16-year-old girl who presented with severe pain and swelling of right scapula for 6 months duration with painful limitation of shoulder movements. After extensive evaluation, we diagnosed ABC of the scapula secondary to fibrous dysplasia which was successfully managed by CT guided percutaneous polidocanol sclerotherapy. One year after the injection, patient is asymptomatic with excellent radiological outcome. Polidocanol is an effective alternative to conventional methods since, it precludes functional disabilities like joint stiffness and shortening which are common with other methods.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app